Paxil birth defects spur defective drugs lawsuits

Posted by Bruce Westbrook

November 2, 2009

For huge pharmaceutical companies which make huge profits, settling a defective drugs lawsuit for millions of dollars may be considered a satisfactory trade-off given such drugs’ billions of dollars in revenues. In fact, some pharmaceutical giants even market drugs which are known to be dangerous, content with a bottom-line strategy of profits at any costs — even human ones.

It’s not known if GlaxoSmithKline PLC of London, England is guilty of such malice when it comes to birth defects caused by its defective drug Paxil. In fact, though a Philadelphia, PA jury in October awarded $2.5 million in compensatory damages to a couple whose child had heart problems after his mother took Paxil during pregnancy, that same jury did not award punitive damages for malice.

Yet Glaxo does have a history of such malice, notably involving the serious harm Paxil also has caused when the antidepressant has led to violent or even suicidal behavior. As they say, where there’s smoke there’s fire — and could be even more fire.

Currently, the greatest concern with Paxil involves birth defects caused by the antidepressants. These not only can impact a newborn infant’s heart, but also the lungs and other vital organs.

If your family has suffered birth defect injury via defective drug Paxil, let a defective drugs lawyer or attorney with Jim S. Adler & Associates fight for your rights in the legal arena. Let us know your needs via the free case evaluation form found on this web page, and a legal representative will respond promptly.

A Paxil defective drugs lawsuit not only can seek financial compensation for your losses – including medical bills and pain and suffering — but also can send a message to pharmaceutical giants that no amount of profits are worth the terrible toll that defective drugs can take on human life.

Share on Facebook